MaxCyte Inc risk profile
53 Elevated one input has moved against it
Measured 21 October 2026 from MXCT's filed statements. Recomputed nightly.
53 (Elevated), driven by Cash conversion at 100, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 65 | Stretched | Volatile | One-year price volatility — 71.2% |
| Operating pressure | 46 | Elevated | Worsening | Operating-margin drift — -152.5 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.05x |
| Leverage and coverage | 0 | Contained | Stable | Net debt to EBITDA |
| Competitive position | 77 | Stretched | Stable | Operating-margin gap against peers — -235.8 percentage points |
| Concentration | 29 | Normal | Worsening | Customer concentration — 676 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.